InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,643.57
(
0.50%
)
US TECH 100
19,918.00
(
0.63%
)
Dow Jones
40,296.16
(
0.74%
)
Brent Oil
84.46
(
-0.16%
)
Bitcoin
63,193.14
(
3.97%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: Gold Seeker post# 7858

Thursday, 01/18/2007 11:06:02 PM

Thursday, January 18, 2007 11:06:02 PM

Post# of 30387
The molecular diagnostics is a subsidiary of Abbott Laboratories and deals in genetic testing.

This is going to need more clarification before you can actually state who will end up with RECAF.

To pay 8.13 billion, you should get a sizable portion of the testing that is currently done. The release also stated that GE would be in a better positon of dealing with automated testing. Since RECAF is not a genetic test, I think it may be going to GE.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up